Olufemi Samuel Amoo

@nimr.gov.ng

Research Fellow/Centre for Human Virology and Genomics/Microbiology
Nigerian Institute of Medical Research, NIMR

Olufemi Samuel Amoo


                  Download Compact PDF  
https://researchid.co/rossddon
Amoo Olufemi Samuel is a Biochemist and Geneticist with research interest in infectious diseases and host pathogen interactions. He is currently the Head of Centre, Centre for Human Virology and Genomics, NIMR, a position he was appointed to head in 2022. He is the Research Lead, Blood Genetics and Transfusion Research, that he hope to nurture to become a research department in Nigerian Institute of Medical Research, NIMR.
Research Scientist, he conducts research into infectious diseases such as HIV/AIDS, Tuberculosis, Lassa fever, Cholera, Yellow fever and other viral hemorrhagic fever using biochemistry, immunogenetics, digital health, bioinformatics, molecular, genetics and computational biology techniques. He is passionate about ensuring most of the diseases of public health interest in Nigeria is addressed and influencing health policy to better the health of Nigerians. He is an innovator and award winning Research Fellow/Scientist.

EDUCATION

Ph.D. Cell Biology and genetics, (Genetics). University of Lagos, Akoka, Lagos State, Nigeria. 10th November, 2021
M. Sc. Cell Biology and Genetics, University of Lagos, Akoka, Lagos State, Nigeria, 25th January, 2012.
M. Sc. Biochemistry, College of medicine, University of Lagos, Idi-Araba, Lagos, Nigeria, 28th March, 2007.
B. Sc. Biochemistry, University of Ilorin, Ilorin, Kwara State, Nigeria, 30th May, 2001.

RESEARCH INTERESTS

Digital epidemiology, implementation research, host-pathogen interactions, immunogenetics, use of bioinformatics and computational biology
336

Scholar Citations

11

Scholar h-index

14

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Rotavirus-Associated Adverse Pregnancy Outcomes among Women Without HIV Compared to Women Living with HIV
    OS Amoo, JI Oraegbu, TI Onuigbo, JA Adebayo, P Obichere, ...
    2026
  • Community-acquired Klebsiella pneumoniae–Its Virulence and Antimicrobial Resistance Genes Complement in Participants Presenting for COVID-19 Testing in Lagos State, Nigeria
    AO Adagbada, JI Yisau, TW Fesobi, MA Fowora, TA Bamidele, ...
    International Journal of Translational Medical Research and Public Health 10 … , 2026
    2026
  • Community-acquired Klebsiella pneumoniae – Its Virulence and Antimicrobial Resistance Genes Complement in Participants Presenting for COVID-19 Testing in Lagos State, Nigeria
    International Journal of Translational Medical Research and Public Health … , 2026
    2026
  • Performance characteristics of the SARS-CoV-2 Isothermal Molecular Assay for point-of-care molecular diagnosis of SARS-CoV-2
    CK Onwuamah, JO Shaibu, OS Amoo, RA Ahmed, BS Abimbola, ...
    medRxiv, 2025.03. 29.25324880 , 2025
    2025
  • Assessment of awareness and levels of preparedness for humanitariandisasters across some geopolitical zones in Nigeria
    Discover Geoscience 3 (32), 17 , 2025
    2025
    Citations: 2
  • Regional Cross-Sectional Based Study and Associated Risk Factors of Porcine Circovirus 2 in Nigerian Pigs (vol 2023, 9201177, 2023)
    KO Afolabi, OS Amoo, T Onuigbo
    TRANSBOUNDARY AND EMERGING DISEASES 2025 (1) , 2025
    2025
  • Corrigendum to “Regional Cross-Sectional Based Study and Associated Risk Factors of Porcine Circovirus 2 in Nigerian Pigs”
    KO Afolabi, OS Amoo, TI Onuigbo
    2025
  • Point-of-care biochemistry for primary healthcare in low-middle income countries: a qualitative inquiry
    FMNO Martínez-Pérez GZ, Adetunji TA, Salas Noriega FJL, Amoo OS, Ugarte-Gil ...
    BMC Primary Care 25 (1), 14 , 2024
    2024
    Citations: 4
  • Assessment Of Awareness And Level Of Preparedness For Humanitarian Disasters In Nigeria
    OS Amoo, OB Awoderu, M Bamidele, EE Afocha, AM Adedeji, MB Ajayi, ...
    2024
    Citations: 1
  • Video observed therapy device improves probability of tuberculosis therapy adherence; a randomised clinical trial at a TB reference clinic in Lagos
    O Amoo, D Kareithi, B Tijani, T Onuigbo, S Karera, B Oladejo, J Oraegbu, ...
    2024
    Citations: 1
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coinfection with Malaria in Selected States in Nigeria
    OO Aina, OS Amoo, KA Osuolale, AK Ojogbede, AP Okwuraiwe, ...
    Advances in Infectious Diseases 14 (2), 442-455 , 2024
    2024
  • healthcare in low-middle income countries: a qualitative inquiry
    GZ Martínez-Pérez, TA Adetunji, FJLS Noriega, OS Amoo, C Ugarte-Gil, ...
    2024
  • Challenges in conducting population-based seroepidemiology survey of COVID-19 in Lagos State, Nigeria
    AK Ojogbede, TA Bamidele, O Aina, T Raheem, A Okwuraiwe, O Amoo, ...
    BMC Public Health 23 (1), 2559 , 2023
    2023
    Citations: 2
  • Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected …
    OO Aina, AA Busari, DA Oladele, C Esezobor, IE Akase, AP Okwuraiwe, ...
    West African Journal of Medicine 40 (10), 1049-1059 , 2023
    2023
  • A survey of chloroquine use for prevention and treatment of COVID-19 in Nigeria
    AY Olukosi, M Fowora, AK Adeneye, E Chukwu, O Aina, O Ajibaye, ...
    African Health Sciences 23 (1), 83 , 2023
    2023
    Citations: 8
  • Regional Cross‐Sectional Based Study and Associated Risk Factors of Porcine Circovirus 2 in Nigerian Pigs
    KO Afolabi, OS Amoo, TI Onuigbo, JI Oraegbu, AA Awoseyi, FO Fasina, ...
    Transboundary and Emerging Diseases 2023 (1), 9201177 , 2023
    2023
    Citations: 3
  • Significance of hematologic abnormalities in COVID-19 severity among infected patients in Lagos, Nigeria
    OS Amoo, N Onyia, TI Onuigbo, SU Vitalis, OF Davies-Bolorunduro, ...
    Bulletin of the National Research Centre 46 (1), 275 , 2022
    2022
    Citations: 2
  • Factors affecting COVID-19 testing behaviours among the population in South Western Nigeria
    OS Amoo, B Tijani, TI Onuigbo, JI Oraegbu, DN Kareithi, JC Obi, ...
    International Journal of Public Health 67, 1604993 , 2022
    2022
    Citations: 11
  • Prevalence and Predictors of High-Risk HPV in Nigeria
    Advances in Infectious Diseases, 12, 745 -747 , 2022
    2022
    Citations: 9
  • Porcine circovirus type 2 and its associated diseases in southwestern Nigeria: Farmers’ perception and level of awareness
    OO Adebowale1, OS Amoo, KO Afolabi, AA Oloye
    JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH 9 (2), 203–210 , 2022
    2022
    Citations: 4

MOST CITED SCHOLAR PUBLICATIONS

  • Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria
    JO Shaibu, CK Onwuamah, AB James, AP Okwuraiwe, OS Amoo, ...
    PloS one 16 (1), e0243271 , 2021
    2021
    Citations: 40
  • Experience of quality management system in a clinical laboratory in Nigeria
    RA Audu, U Sylvester-Ikondu, CK Onwuamah, OB Salu, FA Ige, ...
    African journal of laboratory medicine 1 (1), 1-5 , 2012
    2012
    Citations: 25
  • Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria
    OB Salu, OS Amoo, JO Shaibu, C Abejegah, O Ayodeji, AZ Musa, I Idigbe, ...
    The Pan African Medical Journal 36, 253 , 2020
    2020
    Citations: 22
  • Genetic variations among three major ethnic groups in Nigeria using RAPD
    OA Titilayo, AO Samuel, OO David, TI Adewunmi
    Molecular Biology Research Communications 7 (2), 51 , 2018
    2018
    Citations: 19
  • Comparative performance of SARS-CoV-2 real-time PCR diagnostic assays on samples from Lagos, Nigeria
    CK Onwuamah, AP Okwuraiwe, OB Salu, JO Shaibu, N Ndodo, SO Amoo, ...
    PloS one 16 (2), e0246637 , 2021
    2021
    Citations: 18
  • Experience with hepatitis B viral load testing in Nigeria
    AP Okwuraiwe, OB Salu, CK Onwuamah, OS Amoo, NN Odunukwe, ...
    African Journal of Clinical and Experimental Microbiology 12 (3) , 2011
    2011
    Citations: 18
  • COVID-19 spread patterns is unrelated to malaria co-infections in Lagos, Nigeria
    OS Amoo, OO Aina, AP Okwuraiwe, CK Onwuamah, JO Shaibu, F Ige, ...
    Adv Infect Dis 10 (05), 200-15 , 2020
    2020
    Citations: 17
  • Prevalence and Clinical Characteristics of Coronavirus Disease 2019 Seen at a Testing Centre in Lagos Nigeria.
    AO Salako, OS Amoo, OO Odubela, KA Osuolale, AB James, DA Oladele, ...
    West African Journal of Medicine 38 (1), 54-58 , 2021
    2021
    Citations: 14
  • Socio economic and health challenges of internally-displaced persons as a result of 2012 flooding in Nigeria
    OS Amoo, SI Smith, IAO Ujah, D Oladele, N David, KS Oyedeji, ...
    Ceylon Journal of Science 47 (3) , 2018
    2018
    Citations: 14
  • Immunological and virological response to haart in HIV-1 patients co-infected with hepatitis B and C viruses
    AP Okwuraiwe, RA Audu, OB Salu, CK Onwuamah, OS Amoo, FA Ige, ...
    West African Journal of Medicine 31 (2), 124-128 , 2012
    2012
    Citations: 12
  • Factors affecting COVID-19 testing behaviours among the population in South Western Nigeria
    OS Amoo, B Tijani, TI Onuigbo, JI Oraegbu, DN Kareithi, JC Obi, ...
    International Journal of Public Health 67, 1604993 , 2022
    2022
    Citations: 11
  • Evaluation of respiratory tract bacterial co-infections in SARS-CoV-2 patients with mild or asymptomatic infection in Lagos, Nigeria
    OF Davies-Bolorunduro, MA Fowora, OS Amoo, E Adeniji, KA Osuolale, ...
    Bulletin of the National Research Centre 46 (1), 115 , 2022
    2022
    Citations: 10
  • Comparative assessment of knowledge, attitude/practices and prevention of Lassa fever among community dwellers and contacts of confirmed patients in endemic areas of Ondo State …
    OS Amoo, J Shaibu, O Salu, I Idigbe, Z Musa, G Famokun, O Ezechi, ...
    European Journal of Medical and Health Sciences 3 (4), 137-144 , 2021
    2021
    Citations: 10
  • Implementation of a modified drive-through sampling strategy for SARS-CoV-2-the Nigerian experience
    OS Amoo, AG Ohihoin, AZ Musa, I Idighe, F Ige, T Giwa-Tubosun, S Oloko, ...
    The Pan African Medical Journal 35 (Suppl 2), 107 , 2020
    2020
    Citations: 10
  • Prevalence and Predictors of High-Risk HPV in Nigeria
    Advances in Infectious Diseases, 12, 745 -747 , 2022
    2022
    Citations: 9
  • Surveillance of Viral Hemorrhagic Fever Viruses in Lassa Fever Suspects in Ondo State, Nigeria
    AP Okwuraiwe, O Faye, FA Ige, AB James, JO Shaibu, M Faye, OS Amoo, ...
    European Journal of Medical and Health Sciences 4 (3), 78-81 , 2022
    2022
    Citations: 9
  • Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
    AP Okwuraiwe, CK Onwuamah, JO Shaibu, SO Amoo, FA Ige, AB James, ...
    PLoS One 16 (6), e0252611 , 2021
    2021
    Citations: 9
  • A survey of chloroquine use for prevention and treatment of COVID-19 in Nigeria
    AY Olukosi, M Fowora, AK Adeneye, E Chukwu, O Aina, O Ajibaye, ...
    African Health Sciences 23 (1), 83 , 2023
    2023
    Citations: 8
  • Care Seeking Behavior of Citizens During Pandemics: A Case Study of COVID-19 in Nigeria
    SKBLS B Tijani, O S Amoo*, T Adaramewa, D N Kareithi, A Omavuohrerhe
    Acta Scientific Microbiology 3 (9), 137-152 , 2020
    2020
    Citations: 6
  • Immunological screening of Lassa Virus among Health workers and Contacts of patients of Lassa fever in Ondo State
    JO Shaibu, OB Salu, OS Amoo, I Idigbe, AZ Musa, OC Ezechi, ...
    Immunobiology 226 (3), 152076 , 2021
    2021
    Citations: 5